Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,406,000 | 2,862,000 | 2,183,000 | 2,052,000 | 2,436,000 |
| Marketable Securities | 30,648,000 | 31,019,000 | 30,225,000 | 31,627,000 | 31,275,000 |
| Receivables | 10,388,000 | 9,399,000 | 9,357,000 | 11,371,000 | 11,523,000 |
| Inventories | 6,249,000 | 6,066,000 | 6,166,000 | 6,482,000 | 6,282,000 |
| Income taxes - deferred | 4,869,000 | 4,974,000 | 4,624,000 | N/A | N/A |
| Other current assets | 2,727,000 | 3,473,000 | 3,689,000 | 7,968,000 | 9,919,000 |
| TOTAL | $58,287,000 | $57,793,000 | $56,244,000 | $59,500,000 | $61,435,000 |
| Non-Current Assets | |||||
| PPE Net | 12,179,000 | 12,347,000 | 12,397,000 | 12,359,000 | 12,443,000 |
| Investments And Advances | 17,168,000 | 15,822,000 | 16,406,000 | 15,731,000 | 16,107,000 |
| Intangibles | 80,021,000 | 80,589,000 | 81,904,000 | 82,949,000 | 84,207,000 |
| Other Non-Current Assets | 4,957,000 | 5,257,000 | 5,150,000 | 4,982,000 | 5,143,000 |
| TOTAL | $114,325,000 | $114,015,000 | $115,857,000 | $116,021,000 | $117,900,000 |
| Total Assets | $172,612,000 | $171,808,000 | $172,101,000 | $175,521,000 | $179,335,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,561,000 | 9,319,000 | 6,027,000 | 4,738,000 | 5,214,000 |
| Accounts payable and accrued liabilities | 2,990,000 | 2,546,000 | 3,234,000 | 2,287,000 | 1,978,000 |
| Accrued Expenses | 1,631,000 | 1,758,000 | 1,792,000 | 1,750,000 | 1,430,000 |
| Other current liabilities | 9,346,000 | 10,315,000 | 9,972,000 | 10,774,000 | 12,218,000 |
| TOTAL | $21,938,000 | $24,790,000 | $23,366,000 | $20,373,000 | $23,450,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,267,000 | 27,649,000 | 30,462,000 | 31,812,000 | 31,532,000 |
| Other Non-Current Liabilities | 15,133,000 | 15,369,000 | 16,057,000 | 22,541,000 | 22,999,000 |
| TOTAL | $73,718,000 | $68,950,000 | $72,115,000 | $76,794,000 | $76,908,000 |
| Total Liabilities | $95,656,000 | $93,740,000 | $95,481,000 | $97,167,000 | $100,358,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,340,863 | 6,378,718 | 6,382,925 | 6,481,071 | 6,620,300 |
| Common Shares | 454,000 | 454,000 | 453,000 | 452,000 | 451,000 |
| Retained earnings | 71,627,000 | 72,028,000 | 69,732,000 | 70,381,000 | 67,628,000 |
| Other shareholders' equity | -2,798,000 | -3,059,000 | -2,925,000 | -5,963,000 | -5,999,000 |
| TOTAL | $76,956,000 | $78,068,000 | $76,620,000 | $78,354,000 | $78,977,000 |
| Total Liabilities And Equity | $172,612,000 | $171,808,000 | $172,101,000 | $175,521,000 | $179,335,000 |